comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 01:12:29 - browse：6

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Amazon expands telehealth clinic nationwide

WSS

Vertex non

AstraZeneca bets AAV gene therapy will still deliver the goods

Mitch McConnell episode has important public health takeaway

The high personal cost of affirmative action for Black doctors

Vertex non

How to make Best Hospitals ratings actually useful for patients

leisure time

comprehensive

The need-to-know this morning

Novavax’s money is going in the wrong direction

hotspot

Cancer drug shortages should be causing more outrage

2024 GOP presidential candidates spar over abortion in debate

Alkermes shareholders re

Diversity in medical illustrations gets boost from Chidiebere Ibe

Jerome Adams on the need for new antivirals for Covid

Complete sequence of Y chromosome published for first time

Medicare details structure of new drug price negotiation program

Infectious disease expert Jeanne Marrazzo assumes Fauci role

How to save PrEP access — and even expand it

Departing Stanford president retracts two papers

knowledge

EQRx, failed developer of low

5 important ways Henrietta Lacks changed medical science

Complete sequence of Y chromosome published for first time

Drug firms test therapies to halt Alzheimer’s before symptoms arise

‘Oppenheimer’ and the risks of AI in health care

Infectious disease expert Jeanne Marrazzo assumes Fauci role

focus

Wikipedia

leisure time

explore